Cargando…
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000921/ https://www.ncbi.nlm.nih.gov/pubmed/36900352 http://dx.doi.org/10.3390/cancers15051561 |
_version_ | 1784904003389227008 |
---|---|
author | Said, Medhat M. Broen, Martinus P. G. Swart, Eleonora L. Bartelink, Imke H. Kouwenhoven, Mathilde C. M. |
author_facet | Said, Medhat M. Broen, Martinus P. G. Swart, Eleonora L. Bartelink, Imke H. Kouwenhoven, Mathilde C. M. |
author_sort | Said, Medhat M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10000921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100009212023-03-11 Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? Said, Medhat M. Broen, Martinus P. G. Swart, Eleonora L. Bartelink, Imke H. Kouwenhoven, Mathilde C. M. Cancers (Basel) Editorial MDPI 2023-03-02 /pmc/articles/PMC10000921/ /pubmed/36900352 http://dx.doi.org/10.3390/cancers15051561 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Said, Medhat M. Broen, Martinus P. G. Swart, Eleonora L. Bartelink, Imke H. Kouwenhoven, Mathilde C. M. Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title | Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title_full | Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title_fullStr | Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title_full_unstemmed | Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title_short | Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? |
title_sort | myelotoxicity of temozolomide treatment in patients with glioblastoma is it time for a more mechanistic approach? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000921/ https://www.ncbi.nlm.nih.gov/pubmed/36900352 http://dx.doi.org/10.3390/cancers15051561 |
work_keys_str_mv | AT saidmedhatm myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach AT broenmartinuspg myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach AT swarteleonoral myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach AT bartelinkimkeh myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach AT kouwenhovenmathildecm myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach |